Interestingly, acetylcholinesterase (Ache), a therapeutic target for AD, was one of the top three gene transcripts up-regulated when reducing myeloid Arg1 in APP mice (Figures 8C, E). This evidence concerns the gene ACHE and Alzheimer disease.